XIAOLI Wang,

h-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

Headline

ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology

Fingerprint

Dive into the research topics where XIAOLI Wang, is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

32 Article
1 Chapter
1 Letter
1 Review article

Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm–blast phase
Wang, X., Rampal, R. K., Hu, C. S., Tripodi, J., Farnoud, N., Petersen, B., Rossi, M. R., Patel, M., McGovern, E., Najfeld, V., Iancu-Rubin, C., Lu, M., Davis, A., Kremyanskaya, M., Weinberg, R. S., Mascarenhas, J. & Hoffman, R., 22 Apr 2022, In: JCI insight. 7, 8, e156534.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Scopus citations
Potent In Vitro Peptide Antagonists of the Thrombopoietin Receptor as Potential Myelofibrosis Drugs
Szabo, M., Kowalczyk, W., Tarasova, A., Andrade, J., Be, C. L., Mulder, R., White, J., Meyer, A. G., Schwab, K. E., Cartledge, K., Le, T. C., Arachchilage, A. W., Wang, X., Hoffman, R., Nilsson, S. K., Haylock, D. N. & Winkler, D. A., Mar 2021, In: Advanced Therapeutics. 4, 3, 2000241.
Research output: Contribution to journal › Article › peer-review
What are the molecular mechanisms driving the switch from MPNs to leukemia?
Wang, X. & Hoffman, R., Mar 2021, In: Best Practice and Research in Clinical Haematology. 34, 1, 101254.
Research output: Contribution to journal › Review article › peer-review
3 Scopus citations
Imetelstat, a telomerase inhibitor, is capable of depleting myelofibrosis stem and progenitor cells
Wang, X., Hu, C. S., Petersen, B., Qiu, J., Ye, F., Houldsworth, J., Eng, K., Huang, F. & Hoffman, R., 25 Sep 2018, In: Blood advances. 2, 18, p. 2378-2388 11 p.
Research output: Contribution to journal › Article › peer-review

Open Access
32 Scopus citations
The characteristics of vessel lining cells in normal spleens and their role in the pathobiology of myelofibrosis
Qiu, J., Salama, M. E., Hu, C. S., Li, Y., Wang, X. & Hoffman, R., 22 May 2018, In: Blood advances. 2, 10, p. 1130-1145 16 p.
Research output: Contribution to journal › Article › peer-review

Open Access
9 Scopus citations

New Applied Physics Findings Has Been Reported by Investigators at Mudanjiang Normal University (Pressure-directed Mixed Ionic-electronic To Pure Electronic Conduction Transition and Enhanced Grain Boundary Conductivity In Solid Electrolyte ...)
XIAOLI Wang,
19/12/22
1 item of Media coverage
Press/Media
Australia Patent: Icahn School of Medicine at Mount Sinai, Geron File Application for 'Use of a Janus kinase inhibitor and a telomerase inhibitor for the treatment of myeloproliferative neoplasms'
XIAOLI Wang,
20/05/22
1 item of Media coverage
Press/Media

XIAOLI Wang,

Personal profile

Headline

Fingerprint

Network

Dive into details

Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm–blast phase

Potent In Vitro Peptide Antagonists of the Thrombopoietin Receptor as Potential Myelofibrosis Drugs

What are the molecular mechanisms driving the switch from MPNs to leukemia?

Imetelstat, a telomerase inhibitor, is capable of depleting myelofibrosis stem and progenitor cells

The characteristics of vessel lining cells in normal spleens and their role in the pathobiology of myelofibrosis

New Applied Physics Findings Has Been Reported by Investigators at Mudanjiang Normal University (Pressure-directed Mixed Ionic-electronic To Pure Electronic Conduction Transition and Enhanced Grain Boundary Conductivity In Solid Electrolyte ...)

Australia Patent: Icahn School of Medicine at Mount Sinai, Geron File Application for 'Use of a Janus kinase inhibitor and a telomerase inhibitor for the treatment of myeloproliferative neoplasms'

XIAOLI Wang,

Personal profile

Headline

Fingerprint

Network

Research output

Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm–blast phase

Potent In Vitro Peptide Antagonists of the Thrombopoietin Receptor as Potential Myelofibrosis Drugs

What are the molecular mechanisms driving the switch from MPNs to leukemia?

Imetelstat, a telomerase inhibitor, is capable of depleting myelofibrosis stem and progenitor cells

The characteristics of vessel lining cells in normal spleens and their role in the pathobiology of myelofibrosis

Press/Media

New Applied Physics Findings Has Been Reported by Investigators at Mudanjiang Normal University (Pressure-directed Mixed Ionic-electronic To Pure Electronic Conduction Transition and Enhanced Grain Boundary Conductivity In Solid Electrolyte ...)

Australia Patent: Icahn School of Medicine at Mount Sinai, Geron File Application for 'Use of a Janus kinase inhibitor and a telomerase inhibitor for the treatment of myeloproliferative neoplasms'